Female Hormone Imbalance (Perimenopause, Menopause & PCOS)
About This Condition
Female hormonal dysfunction spans a wide clinical spectrum: polycystic ovary syndrome (PCOS) in reproductive-age women — affecting 1 in 10 and driven primarily by insulin resistance and androgen excess — and perimenopause/menopause in mid-life women, characterized by declining estrogen and progesterone with significant systemic consequences including bone loss, cardiovascular risk, cognitive changes, mood instability, sleep disruption, and genitourinary atrophy. Both are frequently undertreated: PCOS patients are offered birth control or Metformin without metabolic correction; menopausal women are told to "manage symptoms" or prescribed low-dose antidepressants.
.png)
.svg)
.png){kind=logo}
